These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 8144621)
1. The human chorionic somatomammotropin gene enhancer is composed of multiple DNA elements that are homologous to several SV40 enhansons. Jiang SW; Eberhardt NL J Biol Chem; 1994 Apr; 269(14):10384-92. PubMed ID: 8144621 [TBL] [Abstract][Full Text] [Related]
2. The human chorionic somatomammotropin enhancers form a composite silencer in pituitary cells in vitro. Jiang SW; Eberhardt NL Mol Endocrinol; 1997 Aug; 11(9):1233-44. PubMed ID: 9259315 [TBL] [Abstract][Full Text] [Related]
3. Human placental TEF-5 transactivates the human chorionic somatomammotropin gene enhancer. Jiang SW; Wu K; Eberhardt NL Mol Endocrinol; 1999 Jun; 13(6):879-89. PubMed ID: 10379887 [TBL] [Abstract][Full Text] [Related]
4. Human chorionic somatomammotropin enhancer function is mediated by cooperative binding of TEF-1 and CSEF-1 to multiple, low-affinity binding sites. Jiang SW; Trujillo MA; Eberhardt NL Mol Endocrinol; 1997 Aug; 11(9):1223-32. PubMed ID: 9259314 [TBL] [Abstract][Full Text] [Related]
5. Involvement of a protein distinct from transcription enhancer factor-1 (TEF-1) in mediating human chorionic somatomammotropin gene enhancer function through the GT-IIC enhanson in choriocarcinoma and COS cells. Jiang SW; Eberhardt NL J Biol Chem; 1995 Jun; 270(23):13906-15. PubMed ID: 7775450 [TBL] [Abstract][Full Text] [Related]
6. An initiator element is required for maximal human chorionic somatomammotropin gene promoter and enhancer function. Jiang SW; Shepard AR; Eberhardt NL J Biol Chem; 1995 Feb; 270(8):3683-92. PubMed ID: 7876107 [TBL] [Abstract][Full Text] [Related]
7. Human chorionic somatomammotropin gene enhancer activity is dependent on the blockade of a repressor mechanism. Lytras A; Cattini PA Mol Endocrinol; 1994 Apr; 8(4):478-89. PubMed ID: 8052268 [TBL] [Abstract][Full Text] [Related]
8. Tissue-specific expression and thyroid hormone regulation of the endogenous placental growth hormone variant and chorionic somatomammotropin genes in a human choriocarcinoma cell line. Nickel BE; Cattini PA Endocrinology; 1991 May; 128(5):2353-9. PubMed ID: 1708334 [TBL] [Abstract][Full Text] [Related]
9. Human TEF-5 is preferentially expressed in placenta and binds to multiple functional elements of the human chorionic somatomammotropin-B gene enhancer. Jacquemin P; Martial JA; Davidson I J Biol Chem; 1997 May; 272(20):12928-37. PubMed ID: 9148898 [TBL] [Abstract][Full Text] [Related]
10. Characterization of a single strong tissue-specific enhancer downstream from the three human genes encoding placental lactogen. Jacquemin P; Oury C; Peers B; Morin A; Belayew A; Martial JA Mol Cell Biol; 1994 Jan; 14(1):93-103. PubMed ID: 8264656 [TBL] [Abstract][Full Text] [Related]
11. TEF-1 transrepression in BeWo cells is mediated through interactions with the TATA-binding protein, TBP. Jiang SW; Eberhardt NL J Biol Chem; 1996 Apr; 271(16):9510-8. PubMed ID: 8621623 [TBL] [Abstract][Full Text] [Related]
12. Detection of placental growth hormone variant and chorionic somatomammotropin ribonucleic acid expression in human trophoblastic neoplasms by reverse transcriptase-polymerase chain reaction. Lytras A; Bock ME; Dodd JG; Cattini PA Endocrinology; 1994 Jun; 134(6):2461-7. PubMed ID: 7515000 [TBL] [Abstract][Full Text] [Related]
13. "Repair' of the chorionic somatomammotropin-A "enhancer' region reveals a novel functional element in the chorionic somatomammotropin-B enhancer. Lytras A; Surabhi RM; Zhang JF; Jin Y; Cattini PA Mol Cell Endocrinol; 1996 May; 119(1):1-10. PubMed ID: 8793848 [TBL] [Abstract][Full Text] [Related]
14. Human placental lactogen transcriptional enhancer. Tissue specificity and binding with specific proteins. Walker WH; Fitzpatrick SL; Saunders GF J Biol Chem; 1990 Aug; 265(22):12940-8. PubMed ID: 2376582 [TBL] [Abstract][Full Text] [Related]
15. DNA sequences involved in the transcriptional activation of a human placental lactogen gene. Fitzpatrick SL; Walker WH; Saunders GF Mol Endocrinol; 1990 Dec; 4(12):1815-26. PubMed ID: 1964488 [TBL] [Abstract][Full Text] [Related]
16. The SV40 TC-II(kappa B) and the related H-2Kb enhansons exhibit different cell type specific and inducible proto-enhancer activities, but the SV40 core sequence and the AP-2 binding site have no enhanson properties. Kanno M; Fromental C; Staub A; Ruffenach F; Davidson I; Chambon P EMBO J; 1989 Dec; 8(13):4205-14. PubMed ID: 2556264 [TBL] [Abstract][Full Text] [Related]
17. Binding of AP-2 and ETS-domain family members is associated with enhancer activity in the hypersensitive site III region of the human growth hormone/chorionic somatomammotropin locus. Jin Y; Norquay LD; Yang X; Gregoire S; Cattini PA Mol Endocrinol; 2004 Mar; 18(3):574-87. PubMed ID: 14673137 [TBL] [Abstract][Full Text] [Related]
18. In vitro binding of several cell-specific and ubiquitous nuclear proteins to the GT-I motif of the SV40 enhancer. Xiao JH; Davidson I; Macchi M; Rosales R; Vigneron M; Staub A; Chambon P Genes Dev; 1987 Oct; 1(8):794-807. PubMed ID: 2828172 [TBL] [Abstract][Full Text] [Related]
19. The HeLa cell protein TEF-1 binds specifically and cooperatively to two SV40 enhancer motifs of unrelated sequence. Davidson I; Xiao JH; Rosales R; Staub A; Chambon P Cell; 1988 Sep; 54(7):931-42. PubMed ID: 2843293 [TBL] [Abstract][Full Text] [Related]
20. The SV40 enhancer contains two distinct levels of organization. Ondek B; Gloss L; Herr W Nature; 1988 May; 333(6168):40-5. PubMed ID: 2834649 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]